Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Peter Grobusch

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
IJID Regions|July 4, 2025
Tuberculosis treatment outcomes and their related factors in patients with tuberculosis treated at the Antituberculosis Center of Brazzaville, Republic of CongoBreli Bonheur Ngouama, Freisnel Hermeland Mouzinga, Mita Naomie Merveille Dello, et al.
IJID Regions|May 25, 2026
Drug resistance profile and species diversity in tuberculosis mycobacteria isolated from patients with presumptive tuberculosis in Brazzaville, Republic of CongoDarrel Ornelle Elion Assiana, Viny Andzi Elenga, Raoul Ngassaki, et al.
BMC Infectious Diseases|October 3, 2023
Species identification and drug susceptibility testing of non-tuberculous mycobacteria by Line Probe Assay in Lambaréné, Gabon-a cross-sectional studyMicheska Epola Dibamba Ndanga, Jabar Babatundé Pacome Achimi Agbo Abdul, Jean Ronald Edoa, et al.
Scientific Reports|February 9, 2020
Causes of fever in Gabonese children: a cross-sectional hospital-based studyJosé Francisco Fernandes, Jana Held, Magdalena Dorn, et al.
The American Journal of Tropical Medicine and Hygiene|September 25, 2020
Epidemiological, Mycobacteriological, and Clinical Characteristics of Smoking Pulmonary Tuberculosis Patients, in Lambaréné, Gabon: A Cross-Sectional StudyBayode Romeo Adegbite, Jean Ronald Edoa, Pacome Achimi Agbo, et al.
Infection|October 28, 2022
Resistance patterns among drug-resistant tuberculosis patients and trends-over-time analysis of national surveillance data in Gabon, Central AfricaJabar Babatunde Pacome Achimi Agbo Abdul, Bayode Romeo Adegbite, Micheska Epola Dibamba Ndanga, et al.
IJID Regions|March 30, 2026
High two-month mortality in Gabonese adults with and without tuberculosis: A prospective cohort study of patients with presumed pulmonary tuberculosisStefan Fabian Weber, Anne Glaser, Bayodé Roméo Adegbite, et al.
Journal of Clinical Pharmacology|September 30, 2024
Pharmacokinetics of Ganaplacide and Lumefantrine in Adults, Adolescents, and Children with Plasmodium falciparum Malaria Treated with Ganaplacide Plus Lumefantrine Solid Dispersion Formulation: Analysis of Data from a Multinational Phase 2 StudyRamachandra Sangana, Bernhards Ogutu, Adoke Yeka, et al.
The Lancet. Infectious Diseases|June 16, 2023
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trialBernhards Ogutu, Adoke Yeka, Sylvia Kusemererwa, et al.
Annals of Clinical Microbiology and Antimicrobials|May 9, 2025
Drug-resistant tuberculosis profiles among patients presenting at the antituberculosis center of Brazzaville, Republic of CongoBreli Bonheur Ngouama, Jean Claude Djontu, Darrel Ornelle Elion Assiana, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
IJID Regions|July 4, 2025
Tuberculosis treatment outcomes and their related factors in patients with tuberculosis treated at the Antituberculosis Center of Brazzaville, Republic of CongoBreli Bonheur Ngouama, Freisnel Hermeland Mouzinga, Mita Naomie Merveille Dello, et al.
IJID Regions|May 25, 2026
Drug resistance profile and species diversity in tuberculosis mycobacteria isolated from patients with presumptive tuberculosis in Brazzaville, Republic of CongoDarrel Ornelle Elion Assiana, Viny Andzi Elenga, Raoul Ngassaki, et al.
BMC Infectious Diseases|October 3, 2023
Species identification and drug susceptibility testing of non-tuberculous mycobacteria by Line Probe Assay in Lambaréné, Gabon-a cross-sectional studyMicheska Epola Dibamba Ndanga, Jabar Babatundé Pacome Achimi Agbo Abdul, Jean Ronald Edoa, et al.
Scientific Reports|February 9, 2020
Causes of fever in Gabonese children: a cross-sectional hospital-based studyJosé Francisco Fernandes, Jana Held, Magdalena Dorn, et al.
The American Journal of Tropical Medicine and Hygiene|September 25, 2020
Epidemiological, Mycobacteriological, and Clinical Characteristics of Smoking Pulmonary Tuberculosis Patients, in Lambaréné, Gabon: A Cross-Sectional StudyBayode Romeo Adegbite, Jean Ronald Edoa, Pacome Achimi Agbo, et al.
Infection|October 28, 2022
Resistance patterns among drug-resistant tuberculosis patients and trends-over-time analysis of national surveillance data in Gabon, Central AfricaJabar Babatunde Pacome Achimi Agbo Abdul, Bayode Romeo Adegbite, Micheska Epola Dibamba Ndanga, et al.
IJID Regions|March 30, 2026
High two-month mortality in Gabonese adults with and without tuberculosis: A prospective cohort study of patients with presumed pulmonary tuberculosisStefan Fabian Weber, Anne Glaser, Bayodé Roméo Adegbite, et al.
Journal of Clinical Pharmacology|September 30, 2024
Pharmacokinetics of Ganaplacide and Lumefantrine in Adults, Adolescents, and Children with Plasmodium falciparum Malaria Treated with Ganaplacide Plus Lumefantrine Solid Dispersion Formulation: Analysis of Data from a Multinational Phase 2 StudyRamachandra Sangana, Bernhards Ogutu, Adoke Yeka, et al.
The Lancet. Infectious Diseases|June 16, 2023
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trialBernhards Ogutu, Adoke Yeka, Sylvia Kusemererwa, et al.
Annals of Clinical Microbiology and Antimicrobials|May 9, 2025
Drug-resistant tuberculosis profiles among patients presenting at the antituberculosis center of Brazzaville, Republic of CongoBreli Bonheur Ngouama, Jean Claude Djontu, Darrel Ornelle Elion Assiana, et al.
Pageof 8